Antioxidant intervention in rheumatoid arthritis: results of an open pilot study
- PMID: 18274814
- PMCID: PMC2367388
- DOI: 10.1007/s10067-008-0848-6
Antioxidant intervention in rheumatoid arthritis: results of an open pilot study
Abstract
There is evidence that reactive oxygen species play a causal role in auto-immune diseases, such as rheumatoid arthritis (RA). Despite the supporting evidence for a beneficial effect of antioxidants on clinical characteristics of RA, the right balance for optimal effectiveness of antioxidants is largely unknown. To determine the potential beneficial effects of an antioxidant intervention on clinical parameters for RA, an open pilot study was designed. Eight non-smoking female patients with rheumatoid factor + RA and a Disease Activity Score (DAS 28) higher than 2.5 were enrolled in the study. Patients had to be receiving stable non-steroidal anti-inflammatory drug treatment and/or 'second line' medication for at least 3 months. The pilot group consumed 20 g of antioxidant-enriched spread daily during a period of 10 weeks. The intervention was stopped after 10 weeks and was followed by a 'wash-out' period of 4 weeks. At t = 0, t = 10 weeks and t = 14 weeks, patients' condition was assessed by means of DAS. In addition, standard laboratory analyses were performed, and blood-samples for antioxidants were taken. The antioxidant-enriched spread was well tolerated. All laboratory measures of inflammatory activity and oxidative modification were generally unchanged. However, the number of swollen and painful joints were significantly decreased and general health significantly increased, as reflected by a significantly improved (1.6) DAS at t = 10 weeks. The antioxidant effect was considered beneficial as, compared to the scores at t = 0, the DAS significantly reduced at t = 10 weeks. Increase of the DAS (0.7) after the "wash-out period" at t = 14 confirmed a causal relation between changes in clinical condition and antioxidants. This open pilot study aimed to assess the clinical relevance of an antioxidant intervention as a first step in assessing potential beneficial effects of antioxidants on rheumatoid arthritis. These conclusions need to be validated in a larger controlled study population.
Figures
References
- 
    - {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '7230155', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7230155/'}]}
- Lunec J, Halloran SP, White AG, Dormandy L (1981) Freeradical oxidation (peroxidation)products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 8:233–245 - PubMed
 
- 
    - {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1084/jem.184.4.1519', 'is_inner': False, 'url': 'https://doi.org/10.1084/jem.184.4.1519'}, {'type': 'PMC', 'value': 'PMC2192822', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2192822/'}, {'type': 'PubMed', 'value': '8879223', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8879223/'}]}
- McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY (1996) Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184:1519–1524 - PMC - PubMed
 
- 
    - {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/art.21111', 'is_inner': False, 'url': 'https://doi.org/10.1002/art.21111'}, {'type': 'PubMed', 'value': '15986371', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15986371/'}]}
- Remans PH, van Oosterhout M, Smeets TJ, Sanders M, Frederiks WM, Reedquist KA, Tak PP, Breedveld FC, van Laar JM (2005) Intracellular free radical production in synovial T lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 52(7):2003–2009 July - PubMed
 
- 
    - {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8871845', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8871845/'}]}
- Sklodowska M, Gromadzinska J, Biernacka M et al (1996) Vitamin E, thiobarbituric acid reactive substance concentrations and superoxide dismutase activity in the blood of children with juvenile rheumatoid arthritis. Clin Exp rheumatol 14:433–439 - PubMed
 
- 
    - {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1080/03009740600718080', 'is_inner': False, 'url': 'https://doi.org/10.1080/03009740600718080'}, {'type': 'PubMed', 'value': '16766362', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16766362/'}]}
- Oliver JE, Silman AJ (2006) Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol 35(3):169–174 May-Jun - PubMed
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Medical
 
         
               
               
               
              